Patrice Lee

Preclinical Activity of HER2-Selective Tyrosine Kinase Inhibitor Tucatinib as a Single Agent or in Combination with Trastuzumab or Docetaxel in Solid Tumor Models

Anita Kulukian, Patrice Lee, Janelle Taylor et al. · Molecular Cancer Therapeutics · 2020 · 196 citations

Sustained blockade of neurotrophin receptors TrkA, TrkB and TrkC reduces non-malignant skeletal pain but not the maintenance of sensory and sympathetic nerve fibers

Joseph R. Ghilardi, Katie T. Freeman, Juan Miguel Jiménez‐Andrade et al. · Bone · 2010 · 67 citations

Pain Therapy, Pain Syndrome, Health Sciences +13

Synthesis, in vitro and in vivo activity of thiamine antagonist transketolase inhibitors

Allen A. Thomas, Yvan Le Huérou, Jason De Meese et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 56 citations · Full text

Vivo Activity, Biochemistry, Medicine +7

ARRY-520, a novel KSP inhibitor with potent activity in hematological and taxane-resistant tumor models.

Richard Woessner, Brian Tunquist, Christine Lemieux et al. · PubMed · 2009 · 56 citations

Biomechanical defects and rescue of cardiomyocytes expressing pathologic nuclear lamins

Erik Laurini, Valentina Martinelli, Thomas Lanzicher et al. · Cardiovascular Research · 2018 · 54 citations · Full text